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A worldwide surveillance program studying the In
Vitro Activity of Tigecycline and 10 common therapeu-
tic agents against methicillin-resistant Staphylococcus
aureus and Vancomycinresistant Enterococcus species
from 2004—2009
B. Johnson1,∗, M. Renteria1, J. johnson1, R. Badal1, S.
Bouchillon1, D. Hoban1, M. Dowzicky2
1 International Health Management Associates, Inc.,
Schaumburg, IL, USA
2 Pﬁzer Inc, Collegeville, PA, USA
Background: The T.E.S.T. program determined the in
vitro activity against methicillinresistant S. aureus and
vancomycin-resistant Enterococcus spp. of TIG and 10
antimicrobials commonly prescribed for serious gram-
positive infections: amoxicillin-clavulanic acid (AUG),
piperacillin-tazobactam (PT), levoﬂoxacin (LVX), ceftriax-
one (CAX), linezolid (LZD), minocycline (MIN), vancomycin
(VAN), ampicillin (AMP), penicillin (P), and meropenem
(MER). Study strains were collected from 697 laboratories
in 55 countries globally throughout 2004-2009.
Methods: A total of 27,846 clinical isolates (10,806 ente-
rococci, 17,040 S. aureus) were identiﬁed to the species
level at each participating site and conﬁrmed by a central
laboratory. Minimum Inhibitory Concentrations (MICs) were
determined by the local laboratory using broth microdilution
panels. Antimicrobial resistance was interpreted according
to CLSI breakpoints with TIG susceptible breakpoints deﬁned
as <0.5 mcg/ml for S. aureus and <0.25 mcg/ml for entero-
cocci.
Results: 12.8% (1,381/10,806) of enterococci were resis-
tant to vancomycin (VRE), and 42.1% (7,174/17,040) of S.
aureus were resistant to oxacillin (MRSA). Among the van-
comycin resistant E. faecium (VREF), % resistant rates to
other study drugs were LVX 99.3, P 98.5, AMP 98.3, VAN 100,
MIN 10.8 and LZD 0.2. Percent resistant rates for MRSA were
P 100, AMP 100, AUG 75.4, LVX 74.9, PT 65.8 CAX 46.5, IMP
24.4, MIN 1.3, LZD 0.0, and VAN 0.0. TIG inhibited 100% of
the enterococci and S. aureus resistant to other drugs. Modal
TIG MICs for VRE/nonVRE were 0.12/0.12, and 0.12/0.12 for
MRSA/MSSA.
Conclusion: TIG retained potent activity against drug-
resistant S. aureus and enterococcal isolates, inhibiting
100% of all strains tested at their deﬁned breakpoints of 0.5
and 0.25mcg/ml, respectively.
doi:10.1016/j.ijid.2010.02.382
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he survey of risk factors of multi drug resistant of E.
aecalis isolated from clinical samples
. Moniri
Kashan University of Medical Sciences, Kashan, Iran, Islamic
epublic of
Background: During the last decade, enterococci have
ecome important nosocomial pathogens, representing the
econd leading cause of urinary tract infections. This
ncreasing prevalence has been paralleled by the occurrence
f multi-drug resistant (MDR). The aim of this cross-sectional
revalence study was to determine the prevalence and risk
actors of antibiotic resistance of E. faecalis isolated from
linical samples in hospitalized patients in Kashan, Iran.
Methods: This descriptive study was done on clini-
al specimens isolated from hospitalized patients. From
eptember 2007 to 2008, a total of 106 E.faecalis isolates
ere collected from clinical specimens in Kashan hospi-
als. Antimicrobial susceptibility test was determined with
isk diffusion and minimal inhibitory concentration of van-
omycin assayed by E test.
Results: From 128 isolates were found to consist of Ente-
ococcus faecalis 106(82.8%) and Enterococcus faecium 22
17.2%). Resistance rates for E.faecalis were as follows:
rytromycin 52.8%; ciproﬂoxacin 40.6%; gentamicin, 38.7%;
evoﬂoxacin 34%; penicillin, 29.2%; nitrofurantoin 18.9%;
mpicillin, 11.3%; Imipenem 10.4%; and vancomycin, 4.7%
ll isolate were sensitive to linezolid. Multidrug-resistant
MDR) phenotype (resistance to three or more of drugs)
ccurred in 37.7%. Risk factor for a VRE-positive culture
ere antimicrobial usage within 2 months before culture
P = 0.045).
Conclusion: Emergence of multi-resistant E.faecalis and
igh level resistance to vancomycin shown by E.faecalis
trains is of concern because of the decrease in the ther-
peutic options for treatment of infections caused by
nterococci.
oi:10.1016/j.ijid.2010.02.383
4.004
he relationship between macrolide resistance in Strep-
ococcus pneumoniae and consumption of oral macrolides
n Republic of Croatia and City of Zagreb
. Vranes1,∗, J. Knezevic2, B. Bedenic3, D. Stimac4, N.
arza-Davila4, M. Anusic5
Zagreb Institue of Public Health ‘‘Andrija Stampar’’,
agreb, Croatia
Zagreb Institute of Public Health ‘‘Andrija Stampar’’,
agreb, Croatia
School of Medicine, University of Zagreb, Clinical Hospital
enter Zagreb, Zagreb, Croatia
Zagreb Institute of Public Health ‘‘Andrija Stampar’’,
agreb, Croatia
Zagreb Institute of Public Health, Zagreb, Croatia
Background: The aim of this study was to investigate the
elationship between increased resistance of Streptococcus
neumoniae to macrolides and use of macrolides in Croatia
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rom 2001 to 2008, with the special emphasis on differences
n outpatient consumption of macrolides in City of Zagreb
nd total consumption in Republic of Croatia.
Methods: Zagreb Institute of Public Health in collabo-
ation with Croatian Drug Agency collected and analyzed
ata on outpatient consumption of drugs by use of stan-
ardized methods of drug monitoring. Data on the number
nd size of packages were obtained from all pharmacies in
roatia, and based on these data the number of deﬁned
aily doses (DDD) and DDD per 1000 inhabitants per day
DDD/1000/day) were calculated. In the eight year study
eriod upper respiratory isolates of S. pneumoniae were
ollected and antibiotics susceptibility was tested during
ctober, November and December by use of standardized
ethods.
Results: The City of Zagreb led in drug consumption
n Croatia according to counties, followed by Sibenik-Knin
ounty and Dubrovnik-Neretva County. Outpatient utiliza-
ion of macrolides was high in the City of Zagreb and varied
rom 4.67 in 2001 to 3.98 DDD/1000/day in 2008, while in
he rest of Croatia varied from 2.12 to 2.92 DDD/1000/day.
he observed macrolide resistance in S. pneumoniae signif-
cantly raised in 2005 in the City of Zagreb from 22% to 39%,
nd in 2008 recorded macrolide resistance in Zagreb was
8%.
The signiﬁcant increase in macrolide resistance in the
est of Croatia was observed in 2007 and 2008, from 25% in
005 to 34% in 2007 and 40% in 2008, two years after the
etection of increase of macrolide resistance in the City of
agreb.
Conclusion: Further study is needed to clear whether the
lonal spreading of resistant strains from Zagreb to other
arts of Croatia is responsible for increasing macrolide resis-
ance in Croatia, or genetically unrelated strains caused
he high macrolide resistance due to increased macrolide
onsumption at national level.
oi:10.1016/j.ijid.2010.02.384
4.005
lood culture isolates in a tertiary care hospital of Eastern
epal: Trends in antimicrobial resistance
. Khanal ∗, S. Shrestha, N. Gyawali
BP Koirala Institute of Health Sciences, Dharan, Nepal
Background: Bloodstream infections remain the major
ause of morbidity and mortality. Knowledge of pattern of
ntimicrobial agents among local isolates and its changes
ver time plays a major role for selecting appropriate and
ffective therapy. Present study was undertaken to deter-
ine the type and frequency of bacterial isolates obtained
rom blood culture and their antimicrobial resistant pattern
n BP Koirala Institute of Health Sciences (BPKIHS), a tertiary
are hospital in eastern Nepal.
Methods: Blood culture specimens submitted to Depart-
ent of Microbiology, BPKIHS over a duration of 5 years
ere evaluated. Isolation, identiﬁcation and determination
f antimicrobial susceptibility were performed by standard
icrobiological techniques.
Results: Out of total 39542 blood culture samples, 4889
12.36%) yielded the growth. Range of culture positivity
S
a
cternational Congress on Infectious Diseases (ICID) Abstracts
as 9.53—15.07%. Majority of isolates was obtained from
eonates. Except in 1st year, Gram Positive cocci(GPC)
ere isolated more frequently than Gram Negative Bacilli
GNB). Staphylococcus aureus was the predominant organ-
sm among GPC throughout the study period. Enterococci
eplaced Coagulase negative staphylococci as 2nd most com-
on GPC in last 3 years. Acinetobacter spp accounted for
he most common GNB for last 3 years (32-38%). Isola-
ion of Salmonella Typhi decreased from 11.37 to 0.86%
nd that of Salmonella Paratyphi A from 7.33 to 0.64%
ver the time period. Multidrug resistant decreased among
almonellae,however reduced susceptibility to ciproﬂoxacin
as emerged.Among S.aureus, around 26% were found to
e Methicillin resistant. Vancomycin resistance was not
bserved in disc diffusion testing. Above 50% of Enterococci
xhibited resistance to aminoglycosides. Most GNB were
ighly resistant to commonly used antimicrobial agents. For
seudomonas, resistance to Carbenicillin and Piperacillin
ad increased and reached upto 100%.
Conclusion: Both gram positive and gram negative bacte-
ia were responsible for bloodstream infections. Increased
requency of resistance observed in blood culture isolates
owards commonly used antimicrobials in has emerged
s serious matter of concern. Continuous surveillance
ntimicrobial resistance among local isolates is of utmost
mportance for monitoring and early detection of resistance.
oi:10.1016/j.ijid.2010.02.385
4.006
ulticenter evaluation of tigecycline activity in Latin
merica: Report from the SENTRY antimicrobial surveil-
ance program (2009)
.J. Farrell ∗, H. Sader, S.D. Putnam, R.N. jones
JMI Laboratories, North Liberty, IA, USA
Background: Tigecycline, the ﬁrst glycylcycline, presents
therapy option for emerging multidrug-resistant (MDR)
ram-positive (GP) and -negative (GN) pathogens in com-
licated intra-abdominal, skin structure, and respiratory
nfections. Latin American countries have high and increas-
ng prevalence of MDR isolates of Enterobacteriaceae
ESBLs), Acinetobacter spp. (carbapenem-resistant) and
ram-positive cocci (MRSA, VRE). The aim of this study was
o assess the activity of tigecycline and comparator antimi-
robials against recent (2009) isolates from Latin America.
Methods: Ten sites forwarded 2,672 strains to a cen-
ral laboratory (JMI Laboratories, North Liberty, IA, USA).
nfection types (n) were: bloodstream (1139), community
espiratory (59), hospitalized pneumonia (424), skin and
kin structure (514), GP miscellaneous (536). Country (n
ites; n isolates) were: Argentina (2; 641), Brazil (4; 977),
hile (2; 557), and Mexico (2; 497) Susceptibility testing
gainst a large panel of antimicrobials was performed by
LSI methods (M7-A8, 2009). Identiﬁcations were conﬁrmed
nd interpretive/screening criteria were also by CLSI guide-
ines (M100-S19, 2009), except for tigecycline where United
tates - Food and Drug Administration breakpoints were
pplied.
Results: Tigecycline was active against 96-100% of indi-
ated/tabulated species (see Table). Tigecycline MIC90
